Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting.

Edogawa NICHE Prize award ceremony honoring Dr Craig Venter to be held in Toronto, Canada.

News provided by

Oct. 20, 2023 16:50

A

Size

A A A A

TOKYO--(Business Wire / Korea Newswire)--Harshavardhan Sai Sadineni and Srived Meda of Kasturba Medical College, Manipal, India, won the XVIII Fujio Cup Quiz (FCQ) on Stem cells and Regenerative medicine (RM) in the NCRM NICHE 2023; Sri Ramachandra Institute for Higher Education and Research, India and Institut Teknologi Bandung, Indonesia emerged as runners and joined the team of FCQ elites, a privilege bestowed on those who reach the final stage of the multi-level international contest including a quiz in RM, thereby qualifying to nominate the candidate(s) to Edogawa NICHE Prize, instituted in 2018. The Edogawa NICHE Prize awardee of 2020, Dr John Craig Venter will deliver his lecture at the UHN Ajmera Transplant Center, on the 25th October 2023, in conjunction with the Training Program in Regenerative Medicine (TPRM) at the University of Toronto, co-hosted by German Society for Stem Cell Research (GSZ).

FCQ is an active knowledge gaining event in RM started in 2006 in India, as a part of NCRM NICHE, the inaugural anniversary commemorative event of Nichi-in Centre for Regenerative medicine (NCRM), held every October, conducted in Tokyo 2017~2019, and now virtually. NCRM NICHE has triggered novel ideas and collaborations yielding cutting edge solutions in cell therapies such as the Buccal epithelium Expanded and Encapsulated in Scaffold-Hybrid Approach to Urethral Stricture (BEES HAUS) with clinical studies of safety & efficacy and preclinical evidence, tissue engineering technologies for transplant suitable human chondrocytes for cartilage repair with age reversal in vitro, optimized solutions for transport of cells and tissues for processing between hospitals and cell processing facilities. Through a global inter-disciplinary networking, disease modifying adjunct solutions developed for unmet needs viz., Duchenne muscular dystrophy (DMD), multiple sclerosis (MS), Autism spectrum disorders (ASD), and Parkinson’s disease (PD), were presented in the Inter-disciplinary Conclave (IDC).

Prof. Dr. Mihai G. Netea, Radboud University Medical Center, Netherlands, talked on Trained immunity and innate host defense, Dr Shojiro Katoh, President, Edogawa Hospital, on Novel tissue engineering technology enhancing cell therapies for cartilage repair, Mr. Yasutoshi Nishikawa, on Biomaterials for bone reconstruction and Dr Dedeepiya Devaprasad, on Gut microbiome, Gut-brain-axis & Brain health, moderated by Prof. Dr. Jurgen Hescheler, University of Cologne, Germany.

NCRM with cell biology and biomaterial laboratories, in collaboration with academic and industry partners in Japan are researching on the basic origin of diseases at cellular level taking cues from immune system evolution across phylogeny, in vitro culture systems and in vivo biological responders.

Website: https://www.gncorporation.com/

View Korean version of this release

Contact

GN Corporation Co Ltd
Samuel JK Abraham
info@gncorporation.com

This news is a press release provided by GN Corporation Co., Ltd.. Korea Newswire follows these editorial guidelines.

GN Corporation Co., Ltd. News Releases

NCRM NICHE 2023 국제 줄기세포 회의에서 인도의 카스투르바 의과대학 18차 후지오컵 퀴즈 우승

인도 마니팔 소재 카스투르바 의과대학의 하샤바르단 사이 사디네니와 스리베드 메다가 NCRM NICHE 2023에서 줄기세포 및 재생의학(RM)에 대해 XVIII 후지오컵 퀴즈(FCQ)을 획득하고, 인도의 스리 라마찬드라 고등교육연구소와 인도네시아의 반둥공과대학이 차점자로 부상함에 따라 RM 시험을 포함한 다단계 ...

2023년 10월 20일 16:50

Neu REFIX β-glucan reduces muscle fibrosis in Duchenne muscular dystrophy MDX mice, in joint research with Dr. Yoshitsugu Aoki, NCNP, Tokyo, Japan.

Skeletal muscle fibrosis which leads to locomotor dysfunction in Duchenne Muscular Dystrophy (DMD) could be significantly reduced by oral consumption of Neu-REFIX beta 1,3-1,6 glucans alone for 45 days without any other drugs, in MDX mice model of DMD. This research was undertaken joint...

2023년 10월 18일 14:50

... More

More News

All News Releases